- Trials with a EudraCT protocol (22)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (10)
22 result(s) found for: Impaction.
Displaying page 1 of 2.
EudraCT Number: 2006-002571-40 | Sponsor Protocol Number: 231006 | Start Date*: 2007-05-18 | |||||||||||
Sponsor Name:NV Organon | |||||||||||||
Full Title: A randomized, double-blind, active and placebo controlled trial to compare the relative analgesic efficacy and safety of a single intravenous dose of Org 28611 3.0 µg/kg, morphine sulfate 0.12 mg/... | |||||||||||||
Medical condition: Postoperative analgesia | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-005270-11 | Sponsor Protocol Number: BAY1019036/15529 | Start Date*: 2015-02-09 | |||||||||||
Sponsor Name:Bayer HealthCare AG | |||||||||||||
Full Title: Comparative Onset of Action of a Fast Release Aspirin Tablet in a Dental Impaction Pain Model | |||||||||||||
Medical condition: pain following extraction of impacted third molars | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-005049-67 | Sponsor Protocol Number: 19762 | Start Date*: 2018-08-29 | |||||||||||
Sponsor Name:Bayer HealthCare LLC | |||||||||||||
Full Title: A Randomized, Double-Blind, Placebo-Controlled Trial to Compare the Duration of Analgesic Efficacy and Safety of Naproxen Sodium Tablets and Ibuprofen Tablets in Postsurgical Dental Pain | |||||||||||||
Medical condition: Pain relief | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-002811-33 | Sponsor Protocol Number: LAINCO1107 | Start Date*: 2017-12-11 | |||||||||||
Sponsor Name:LAINCO S.A | |||||||||||||
Full Title: Unilateral, open and randomized phase IV study of 2 groups to assess the degree of comfort with simple Emuliquen® in patients undergoing proctological surgery | |||||||||||||
Medical condition: Surgery proctological | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-004083-62 | Sponsor Protocol Number: steroid3848 | Start Date*: 2019-09-06 |
Sponsor Name:Semmelweis University, Oro-Maxillofacial Surgery and Stomatology | ||
Full Title: Effect of preoperative intramasseteric methylprednisolone injection on the post-operative sequelae of lower third molar surgery: a placebo controlled, randomized, double-blinded study | ||
Medical condition: post-operative swelling, trismus, pain | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: HU (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2014-005278-12 | Sponsor Protocol Number: BAY1019036/15082 | Start Date*: 2015-02-09 | |||||||||||
Sponsor Name:Bayer HealthCare AG | |||||||||||||
Full Title: A Multicenter, Double-Blind, Randomized, Parallel, Placebo-Controlled Trial Assessing the Analgesic Efficacy of a Single, Oral Dose of a Fast Release Aspirin 650 mg in Postsurgical Dental Pain | |||||||||||||
Medical condition: postsurgical (extraction) dental pain | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-005271-81 | Sponsor Protocol Number: BAY1019036/15120 | Start Date*: 2015-02-09 | |||||||||||
Sponsor Name:Bayer HealthCare AG | |||||||||||||
Full Title: A Multicenter, Double-Blind, Randomized, Parallel, Placebo-Controlled Trial Assessing the Analgesic Efficacy of a Single, Oral Dose of a Fast Release Aspirin 1000 mg in Postsurgical Dental Pain | |||||||||||||
Medical condition: postsurgical dental pain | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-003513-33 | Sponsor Protocol Number: 21069 | Start Date*: 2020-05-20 | ||||||||||||||||
Sponsor Name:Bayer HealthCare LLC | ||||||||||||||||||
Full Title: A Randomized, Double-Blind, Single-Dose, Parallel, Placebo-Controlled Trial to Determine the Dose of Caffeine in a Fixed Dose Combination Tablet of Naproxen Sodium and Caffeine to Effectively Allev... | ||||||||||||||||||
Medical condition: Pain, Postoperative | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: Outside EU/EEA | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2020-004112-10 | Sponsor Protocol Number: PROTECTA | Start Date*: 2020-12-16 |
Sponsor Name:Ghent University Hospital | ||
Full Title: Randomized controlled trial comparing micronized progesterone (Amelgen ®) 400 mg BID versus 400 mg TID for luteal support in artificial vitrified/warmed single blastocyst transfer cycles with low p... | ||
Medical condition: Patients who undergo artificial vitrified/warmed single blastocyst transfer cycles with low progesterone (defined as <10mcg/l) on day of embryo transfer. | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: BE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2014-001485-99 | Sponsor Protocol Number: BUL-2/EER | Start Date*: 2015-12-08 | |||||||||||
Sponsor Name:Dr. Falk Pharma GmbH | |||||||||||||
Full Title: Double-blind, randomized, placebo-controlled, phase III study on the efficacy and tolerability of a 48-week treatment with two different doses of budesonide effervescent tablets vs. placebo for mai... | |||||||||||||
Medical condition: Maintenance of remission in eosinophilic esophagitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) BE (Completed) GB (GB - no longer in EU/EEA) ES (Completed) NL (Completed) DK (Prematurely Ended) IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2022-003274-22 | Sponsor Protocol Number: 22093 | Start Date*: 2022-10-25 | ||||||||||||||||
Sponsor Name:Bayer HealthCare LLC | ||||||||||||||||||
Full Title: A Randomized, Double-Blind, Single-Dose, Parallel, Placebo-Controlled Pivotal Trial to Confirm the Efficacy of a Fixed Dose Combination Tablet of Naproxen Sodium and Caffeine to Effectively Allevia... | ||||||||||||||||||
Medical condition: Postoperative dental pain | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: Outside EU/EEA | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2006-001725-25 | Sponsor Protocol Number: RSA-HIP220306 | Start Date*: 2007-08-09 | |||||||||||
Sponsor Name:GREATER GLASGOW HEALTH BOARD | |||||||||||||
Full Title: REVISION HP REPLACEMENT - ACETABULAR IMPACTION GRAFTING - A RADIOSTEREOMETRIC COMPARISON BETWEEN FRESH FROZEN ALLOGRAFT AND MARROW-DEPLETED BONE WITH CALCIUM PHOSPHATE PLUS OR MINUS BONE MORPHOGENI... | |||||||||||||
Medical condition: REVISION HIP REPLACEMENT | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-005272-28 | Sponsor Protocol Number: BAYH6689/15142 | Start Date*: 2015-02-09 | |||||||||||
Sponsor Name:Bayer HealthCare AG | |||||||||||||
Full Title: A Randomized, Double-Blind, Placebo Controlled Trial to Assess the Analgesic Efficacy and Safety of Extended Release Naproxen Sodium Tablets in Postsurgical Dental Pain | |||||||||||||
Medical condition: Pain, Postoperative | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-001133-18 | Sponsor Protocol Number: PH-2006-1 | Start Date*: 2006-05-25 | |||||||||||
Sponsor Name:Pharmos Corp. | |||||||||||||
Full Title: CANNABINOR DENTAL IMPACTION PAIN STUDY PROOF-OF-CONCEPT DOSE-RANGING STUDY | |||||||||||||
Medical condition: Cannabinor is as an analgesic and anti-inflammatory agent. By its nature, it has been designed to be more active at the CB2 peripheral receptors and have less activity at the central CB1 receptors.... | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-003516-39 | Sponsor Protocol Number: BUL-3/EER | Start Date*: 2021-04-28 | |||||||||||
Sponsor Name:Dr. Falk Pharma GmbH | |||||||||||||
Full Title: Double-blind, randomized phase III trial in adult and adolescent patients with eosinophilic esophagitis to prove superiority compared to placebo of an episodic and/or a continuous 48-week treatment... | |||||||||||||
Medical condition: Maintenance of remission in eosinophilic esophagitis | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) ES (Completed) IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-011663-37 | Sponsor Protocol Number: 09PUK/DCsc04 | Start Date*: 2009-07-28 | |||||||||||
Sponsor Name:IBSA, Institut Biochimique SA | |||||||||||||
Full Title: Multicentre, randomized, double-blind, active comparator-and placebo-controlled, parallel-group phase III clinical study for the evaluation of Diclofenac HPBCD 25, 50 mg/ml administered as a single... | |||||||||||||
Medical condition: acute moderate-to-severe post-surgical pain from dental surgery (impacted 3rd molar extraction) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: Removed from public view |
EudraCT Number: 2014-004176-35 | Sponsor Protocol Number: AH-09-10 | Start Date*: 2015-06-26 |
Sponsor Name:Pfizer | ||
Full Title: Evaluation Of The Efficacy Of A Novel Ibuprofen Formulation In The Treatment Of Post Surgical Dental Pain: Study I | ||
Medical condition: Post Surgical Dental Pain | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2014-005269-66 | Sponsor Protocol Number: BAYH6689/13130 | Start Date*: 2015-02-09 | |||||||||||
Sponsor Name:Bayer HealthCare AG | |||||||||||||
Full Title: A Multicenter, Double-Blind, Randomized, Parallel, Placebo-Controlled Trial Assessing the Analgesic Efficacy of a Single, Oral Dose of an Extended Release Naproxen Sodium Tablet in Postsurgical Den... | |||||||||||||
Medical condition: Toothache | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-004655-23 | Sponsor Protocol Number: CR4056-2-03 | Start Date*: 2018-09-24 | |||||||||||
Sponsor Name:Rottapharm Biotech s.r.l. | |||||||||||||
Full Title: A randomized, double-blind, active- and placebo-controlled, parallel group, single dose, multicentre study to assess the analgesic effect of CR4056 in postoperative dental pain | |||||||||||||
Medical condition: Postoperative dental pain | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: PL (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-004384-31 | Sponsor Protocol Number: SAG/0211PFC-11S1 | Start Date*: 2015-06-10 | |||||||||||
Sponsor Name:Sucampo AG | |||||||||||||
Full Title: A Multicentre, Long-term Safety, Efficacy and Pharmacokinetics Study of Lubiprostone in Paediatric Subjects Aged ≥6 to <18 years with Functional Constipation | |||||||||||||
Medical condition: functional constipation in paediatric patients | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) GB (Completed) DE (Completed) ES (Ongoing) NL (Completed) FR (Ongoing) PL (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
